ALB and neoplasm: After effective platelet inhibition by PFTBA@HSA NPs, the tumour vessel barriers were successfully disrupted along with an enhanced tumour vessel permeability (Figure 2D) and a decreased degree of tumour hypoxia (Figure 2E).